334 related articles for article (PubMed ID: 23326362)
1. The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.
Oudman I; Clark JF; Brewster LM
PLoS One; 2013; 8(1):e52879. PubMed ID: 23326362
[TBL] [Abstract][Full Text] [Related]
2. Creatine kinase kinetics, ATP turnover, and cardiac performance in hearts depleted of creatine with the substrate analogue beta-guanidinopropionic acid.
Shoubridge EA; Jeffry FM; Keogh JM; Radda GK; Seymour AM
Biochim Biophys Acta; 1985 Oct; 847(1):25-32. PubMed ID: 4052460
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent changes in cardiac muscle metabolism upon replacement of creatine by beta- guanidinopropionic acid.
Field ML; Unitt JF; Radda GK; Henderson C; Seymour AM
Biochem Soc Trans; 1991 Apr; 19(2):208S. PubMed ID: 1889584
[No Abstract] [Full Text] [Related]
4. In vivo brain phosphocreatine and ATP regulation in mice fed a creatine analog.
Holtzman D; Meyers R; O'Gorman E; Khait I; Wallimann T; Allred E; Jensen F
Am J Physiol; 1997 May; 272(5 Pt 1):C1567-77. PubMed ID: 9176148
[TBL] [Abstract][Full Text] [Related]
5. Effects of the creatine analogue beta-guanidinopropionic acid on skeletal muscles of mice deficient in muscle creatine kinase.
van Deursen J; Jap P; Heerschap A; ter Laak H; Ruitenbeek W; Wieringa B
Biochim Biophys Acta; 1994 May; 1185(3):327-35. PubMed ID: 8180237
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain.
O'Gorman E; Beutner G; Wallimann T; Brdiczka D
Biochim Biophys Acta; 1996 Sep; 1276(2):161-70. PubMed ID: 8816948
[TBL] [Abstract][Full Text] [Related]
7. Decreasing intramuscular phosphagen content simultaneously increases plasma membrane FAT/CD36 and GLUT4 transporter abundance.
Pandke KE; Mullen KL; Snook LA; Bonen A; Dyck DJ
Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R806-13. PubMed ID: 18650314
[TBL] [Abstract][Full Text] [Related]
8. Non-insulin and non-exercise related increase of glucose utilization in rats and mice.
Ohira Y; Ishine S; Tabata I; Kurata H; Wakatsuki T; Sugawara S; Yasui W; Tanaka H; Kuroda Y
Jpn J Physiol; 1994; 44(4):391-402. PubMed ID: 7869601
[TBL] [Abstract][Full Text] [Related]
9. Energetic status and mitochondrial oxidative capacity of rat skeletal muscle in response to creatine analogue ingestion.
Freyssenet D; Berthon P; Barthélémy JC; Busso T; Geyssant A; Denis C
Biochim Biophys Acta; 1995 Mar; 1228(2-3):211-5. PubMed ID: 7893727
[TBL] [Abstract][Full Text] [Related]
10. Actions of the creatine analogue beta-guanidinopropionic acid on rat heart mitochondria.
Clark JF; Khuchua Z; Kuznetsov AV; Vassil'eva E; Boehm E; Radda GK; Saks V
Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):211-6. PubMed ID: 8198536
[TBL] [Abstract][Full Text] [Related]
11. Brain ATP metabolism in hypoxia resistant mice fed guanidinopropionic acid.
Holtzman D; Brown M; O'Gorman E; Allred E; Wallimann T
Dev Neurosci; 1998; 20(4-5):469-77. PubMed ID: 9778586
[TBL] [Abstract][Full Text] [Related]
12. Brain creatine phosphate and creatine kinase in mice fed an analogue of creatine.
Holtzman D; McFarland E; Moerland T; Koutcher J; Kushmerick MJ; Neuringer LJ
Brain Res; 1989 Mar; 483(1):68-77. PubMed ID: 2706511
[TBL] [Abstract][Full Text] [Related]
13. The acute effect of beta-guanidinopropionic acid versus creatine or placebo in healthy men (ABC Trial): study protocol for a randomized controlled trial.
Karamat FA; Horjus DL; Haan YC; van der Woude L; Oudman I; van Montfrans GA; Clark JF; Brewster LM
Trials; 2015 Feb; 16():56. PubMed ID: 25888414
[TBL] [Abstract][Full Text] [Related]
14. Myocardial adaptation to creatine deficiency in rats fed with beta-guanidinopropionic acid, a creatine analogue.
Mekhfi H; Hoerter J; Lauer C; Wisnewsky C; Schwartz K; Ventura-Clapier R
Am J Physiol; 1990 Apr; 258(4 Pt 2):H1151-8. PubMed ID: 2184680
[TBL] [Abstract][Full Text] [Related]
15. A 31P-nuclear magnetic resonance study of skeletal muscle metabolism in rats depleted of creatine with the analogue beta-guanidinopropionic acid.
Shoubridge EA; Radda GK
Biochim Biophys Acta; 1984 Sep; 805(1):79-88. PubMed ID: 6477974
[TBL] [Abstract][Full Text] [Related]
16. Changes of contractile properties of extensor digitorum longus in response to creatine-analogue administration and/or hindlimb suspension in rats.
Wakatsuki T; Ohira Y; Nakamura K; Asakura T; Ohno H; Yamamoto M
Jpn J Physiol; 1995; 45(6):979-89. PubMed ID: 8676581
[TBL] [Abstract][Full Text] [Related]
17. The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency.
Kapelko VI; Kupriyanov VV; Novikova NA; Lakomkin VL; Steinschneider AYa ; Severina MYu ; Veksler VI; Saks VA
J Mol Cell Cardiol; 1988 Jun; 20(6):465-79. PubMed ID: 3216403
[TBL] [Abstract][Full Text] [Related]
18. Use of dietary supplementation with β-guanidinopropionic acid to alter the muscle phosphagen system, postmortem metabolism, and pork quality.
Scheffler TL; Rosser AL; Kasten SC; Scheffler JM; Gerrard DE
Meat Sci; 2013 Oct; 95(2):264-71. PubMed ID: 23743031
[TBL] [Abstract][Full Text] [Related]
19. The acute effects of the creatine analogue, beta-guanidinopropionic acid, on cardiac energy metabolism and function.
Unitt JF; Radda GK; Seymour AM
Biochim Biophys Acta; 1993 Jun; 1143(1):91-6. PubMed ID: 8499456
[TBL] [Abstract][Full Text] [Related]
20. Reduced growth of Ehrlich ascites tumor cells in creatine depleted mice fed beta-guanidinopropionic acid.
Ohira Y; Ishine S; Inoue N; Yunoki K
Biochim Biophys Acta; 1991 Sep; 1097(2):117-22. PubMed ID: 1911884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
